PD-L2 glycosylation promotes immune evasion and predicts anti-EGFR efficacy

• Min Li,
• Yiqi Xu,
• Yuqing Wang,
• Xuan Zhou,
• Mei Mei,
• Jingxuan Yang,
• Zhenyue Gao,
• Ruxin Hu,
• Yuhong Wang,
• Zheng Su,
• Xiaoyue Zhang,
• Yu Ren

Affiliations

Min Li

Department of Medicine, Department of Surgery, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA

Yiqi Xu

Department of Cell Biology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, People`s Republic of China

Yuqing Wang

Department of Cell Biology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, People`s Republic of China

Xuan Zhou

Department of Maxillofacial and Otorhinolaryngology Oncology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, People`s Republic of China

Mei Mei

Department of Cell Biology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, People`s Republic of China

Jingxuan Yang

Department of Medicine, Department of Surgery, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA

Zhenyue Gao

Department of Cell Biology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, People`s Republic of China

Ruxin Hu

Department of Cell Biology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, People`s Republic of China

Yuhong Wang

Department of Genetics, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, People`s Republic of China

Zheng Su

Department of Cell Biology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, People`s Republic of China

Xiaoyue Zhang

Department of Maxillofacial and Otorhinolaryngology Oncology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, People`s Republic of China

Yu Ren

Department of Genetics, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, People`s Republic of China